secwatch.observer — SEC 8-K summary
======================================

Issuer:     NextCure, Inc. (NXTC)
CIK:        0001661059
Form:       8-K
Filed at:   2022-06-23T23:59:59+00:00
Accession:  0001104659-22-073939
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

NextCure shareholders elect three Class III directors and ratify Ernst & Young auditor
--------------------------------------------------------------------------------

- Elected David Kabakoff (11,548,824 for, 1,187,004 against), Michael Richman (11,609,302 for, 1,124,238 against), and Stephen W. Webster (11,530,304 for, 1,202,184 against) as Class III directors.
- Ratified Ernst & Young as independent auditor for FY2022 with 17,631,748 for, 53,399 against, 79,774 abstain.
- Broker non-votes on director election totaled 4,783,701, with no broker non-votes on ratification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1661059/000110465922073939/0001104659-22-073939-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1661059/000110465922073939/tm2219328d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-22-073939

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer